FDA approves Moderna flu vaccine

The U.S. Food and Drug Administration granted approval to Moderna's seasonal flu vaccine, adding another product to the company's portfolio.

The approval was announced late Wednesday, after a reported disagreement between Moderna and former FDA officials.

Although Moderna is shifting its public focus toward cancer therapies, the flu vaccine clearance demonstrates that the company continues to pursue vaccine development.